- Home
- BDTX vs OABI Comparison
BDTX vs OABI Comparison
Compare BDTX & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- OABI
- Stock Information
- Founded
- BDTX 2014
- OABI 2012
- Country
- BDTX United States
- OABI United States
- Employees
- BDTX N/A
- OABI N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- BDTX Health Care
- OABI Health Care
- Exchange
- BDTX Nasdaq
- OABI Nasdaq
- Market Cap
- BDTX 220.3M
- OABI 239.0M
- IPO Year
- BDTX 2020
- OABI N/A
- Fundamental
- Price
- BDTX $3.95
- OABI $1.48
- Analyst Decision
- BDTX Strong Buy
- OABI Strong Buy
- Analyst Count
- BDTX 5
- OABI 3
- Target Price
- BDTX $10.40
- OABI $6.67
- AVG Volume (30 Days)
- BDTX 812.4K
- OABI 540.6K
- Earning Date
- BDTX 11-05-2025
- OABI 11-04-2025
- Dividend Yield
- BDTX N/A
- OABI N/A
- EPS Growth
- BDTX N/A
- OABI N/A
- EPS
- BDTX 0.25
- OABI N/A
- Revenue
- BDTX $70,000,000.00
- OABI $23,027,000.00
- Revenue This Year
- BDTX N/A
- OABI N/A
- Revenue Next Year
- BDTX N/A
- OABI $48.89
- P/E Ratio
- BDTX $15.76
- OABI N/A
- Revenue Growth
- BDTX N/A
- OABI 6.05
- 52 Week Low
- BDTX $1.20
- OABI $1.22
- 52 Week High
- BDTX $4.45
- OABI $4.87
- Technical
- Relative Strength Index (RSI)
- BDTX 55.41
- OABI 39.86
- Support Level
- BDTX $3.71
- OABI $1.45
- Resistance Level
- BDTX $4.08
- OABI $1.56
- Average True Range (ATR)
- BDTX 0.24
- OABI 0.09
- MACD
- BDTX -0.04
- OABI -0.02
- Stochastic Oscillator
- BDTX 35.90
- OABI 8.70
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.